Does low adrenal DHEA-S contribute to low testosterone after menopause?

After the menopausal transition, direct ovarian secretion of sex steroids declines significantly, shifting the primary responsibility for maintaining androgen levels to the peripheral conversion of adrenal precursors.

Physiological mechanisms of postmenopausal androgen synthesis

• Intracrine conversion: Biologically inactive adrenal dehydroepiandrosterone sulfate (DHEA-S) serves as the dominant circulating reservoir for local conversion. Peripheral tissues, including adipose tissue, skin, and liver, utilize their own enzymatic machinery to convert DHEA-S directly into active testosterone.
• Dominant androgenic source: Because systemic ovarian secretion is compromised, these adrenal-derived precursors account for more than 80% of total postmenopausal androgenic activity through localized intracrine pathways.

Clinical correlations and therapeutic impacts

• Precursor-product association: Serum DHEA-S and testosterone levels decline in tandem during age-related adrenopause, showing a moderate positive correlation ($r \approx 0.55$). Approximately 70% of postmenopausal women presenting with clinical androgen deficiency symptoms exhibit concurrent reductions in total testosterone, free testosterone, and DHEA-S.
• Interventional evidence: Clinical trials demonstrate that oral DHEA supplementation significantly increases circulating DHEA-S, which predictably drives dose-dependent increases in downstream testosterone.
• Impact of oral estrogen: Conversely, therapies like oral estrogen replacement can exacerbate free testosterone deficiency. Oral estrogen significantly increases Sex Hormone-Binding Globulin (SHBG) levels—which binds and inactivates circulating testosterone—while concurrently suppressing adrenal output, lowering DHEA-S and further depleting downstream androgen synthesis.

Bottom line

• In postmenopausal women, adrenal DHEA-S is the primary precursor driving peripheral, intracrine testosterone synthesis; consequently, depleted DHEA-S levels act as a direct substrate bottleneck that contributes to low total and free testosterone.